Recruiting Study of Ravulizumab in Pediatric Participants With Primary IgAN NCT07024563 Conditions Autoimmune Diseases, Blood Coagulation Disorders, Cardiovascular Diseases, +36 more Locations Research Site — Palo Alto, California, United States Research Site — Aurora, Colorado, United States Research Site — Beijing, China Research Site — Shanghai, China View all 15 locations View more locations Show fewer locations Loading locations... View Trial Details
